Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315903 | PMC |
| http://dx.doi.org/10.1128/JCM.00643-21 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Measurement of multijet azimuthal correlations and determination of the strong coupling in proton-proton collisions at .
Eur Phys J C Part Fields
August 2024
A measurement is presented of a ratio observable that provides a measure of the azimuthal correlations among jets with large transverse momentum . This observable is measured in multijet events over the range of - based on data collected by the CMS experiment in proton-proton collisions at a centre-of-mass energy of 13 , corresponding to an integrated luminosity of 134 . The results are compared with predictions from Monte Carlo parton-shower event generator simulations, as well as with fixed-order perturbative quantum chromodynamics (pQCD) predictions at next-to-leading-order (NLO) accuracy obtained with different parton distribution functions (PDFs) and corrected for nonperturbative and electroweak effects.
View Article and Find Full Text PDFLuminosity determination using Z boson production at the CMS experiment.
Eur Phys J C Part Fields
January 2024
The measurement of Z boson production is presented as a method to determine the integrated luminosity of CMS data sets. The analysis uses proton-proton collision data, recorded by the CMS experiment at the CERN LHC in 2017 at a center-of-mass energy of 13. Events with Z bosons decaying into a pair of muons are selected.
View Article and Find Full Text PDFBaseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients.
Clin Cancer Res
October 2023
GEICAM Spanish Breast Cancer Group, Madrid, Spain.
Purpose: Prognostic and predictive biomarkers to cyclin-dependent kinases 4 and 6 inhibitors are lacking. Circulating tumor DNA (ctDNA) can be used to profile these patients and dynamic changes in ctDNA could be an early predictor of treatment efficacy. Here, we conducted plasma ctDNA profiling in patients from the PEARL trial comparing palbociclib+fulvestrant versus capecitabine to investigate associations between baseline genomic landscape and on-treatment ctDNA dynamics with treatment efficacy.
View Article and Find Full Text PDFAuthor Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Nature
July 2023
Baillie Gifford Pandemic Science Hub, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!